May 2026: $$ Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome
Project description:
When two rare autoimmune diseases develop simultaneously — immune thrombocytopenia (ITP), in which the immune system attacks the body's own platelets, and antiphospholipid syndrome (APS), which causes life-threatening blood clots — a dangerous dilemma arises: the body risks bleeding and clotting at the same time.